Taxonomy: Cellular organisms; Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata; Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota; Mammalia; Theria; Eutheria; Boreoeutheria; Laurasiatheria; Carnivora; Feliformia,
Latin Name:
Paguma larvata
Tested tissues: Frontal, Kidney, Liver, Lung, Spleen,
Project | Date | Technology | Tissue | Condition | Cell | PMID/DOI |
---|---|---|---|---|---|---|
Vthunter_0007 | 2021.04 | 10X Genomics | Frontal | Normal | 6593 | Link |
Vthunter_0008 | 2021.04 | 10X Genomics | Kidney | Normal | 1930 | Link |
Vthunter_0009 | 2021.04 | 10X Genomics | Liver | Normal | 34029 | Link |
Vthunter_0010 | 2021.04 | 10X Genomics | Lung | Normal | 12863 | Link |
Vthunter_0011 | 2021.04 | 10X Genomics | Spleen | Normal | 9682 | Link |
Virus | Virus Name | GeneTop 5 cell types expressing viral receptor ordered by expression proportion |
---|---|---|
Rabies lyssavirus | ||
Encephalomyocarditis virus |
Spleen-Macrophages : 93.90% ; Spleen-T follicular helper cells : 93.54% ; Spleen-T cells : 83.65% ; Spleen-Dendritic cells : 79.06% ; Spleen-B cells : 78.26% ; |
|
Severe acute respiratory syndrome coronavirus 2 |
Spleen-T cells : 93.64% ; Lung-ATI : 77.51% ; Lung-ATII : 67.39% ; Spleen-Endothelial cells : 67.14% ; Lung-Endothelial cells : 57.66% ; |
|
Foot-and-mouth disease virus |
Spleen-Natural killer cells : 93.46% ; Liver-Cholangiocytes : 86.88% ; Lung-ATI : 80.40% ; Lung-Ciliated cells : 77.73% ; Kidney-Distal convoluted tubule cells : 72.17% ; Lung-ATI : 91.98% ; Lung-ATII : 91.14% ; Lung-Ciliated cells : 71.82% ; Lung-Fibroblasts : 64.20% ; Lung-Epithelial cells : 62.04% ; Lung-ATI : 73.85% ; Lung-Epithelial cells : 66.42% ; Spleen-B cells : 62.66% ; Spleen-Fibroblasts : 59.49% ; Lung-ATII : 55.82% ; Lung-ATI : 64.28% ; Lung-Epithelial cells : 48.18% ; Spleen-Macrophages : 42.48% ; Lung-Ciliated cells : 40.45% ; Spleen-B cells : 40.28% ; |
|
Human alphaherpesvirus 1 |
Spleen-Natural killer cells : 93.46% ; Liver-Cholangiocytes : 86.88% ; Lung-ATI : 80.40% ; Lung-Ciliated cells : 77.73% ; Kidney-Distal convoluted tubule cells : 72.17% ; Lung-ATI : 91.98% ; Lung-ATII : 91.14% ; Lung-Ciliated cells : 71.82% ; Lung-Fibroblasts : 64.20% ; Lung-Epithelial cells : 62.04% ; Lung-ATI : 64.28% ; Lung-Epithelial cells : 48.18% ; Spleen-Macrophages : 42.48% ; Lung-Ciliated cells : 40.45% ; Spleen-B cells : 40.28% ; |
|
Coxsackievirus B1 |
Lung-ATI : 91.98% ; Lung-ATII : 91.14% ; Lung-Ciliated cells : 71.82% ; Lung-Fibroblasts : 64.20% ; Lung-Epithelial cells : 62.04% ; Lung-ATI : 78.41% ; Frontal-Excitatory neurons : 63.97% ; Lung-Ciliated cells : 55.91% ; Lung-ATII : 43.74% ; Liver-Cholangiocytes : 43.73% ; Lung-ATI : 64.28% ; Lung-Epithelial cells : 48.18% ; Spleen-Macrophages : 42.48% ; Lung-Ciliated cells : 40.45% ; Spleen-B cells : 40.28% ; |
|
Coxsackievirus A9 | ||
Equid alphaherpesvirus 1 |
Spleen-Regulatory T cells : 88.97% ; Spleen-B cells : 74.04% ; Spleen-Naive T cells : 67.97% ; Spleen-Endothelial cells : 48.50% ; Spleen-Dendritic cells : 45.44% ; Lung-ATI : 73.85% ; Lung-Epithelial cells : 66.42% ; Spleen-B cells : 62.66% ; Spleen-Fibroblasts : 59.49% ; Lung-ATII : 55.82% ; |
|
Influenza A virus |
Lung-ATI : 88.95% ; Frontal-Excitatory neurons : 84.30% ; Lung-ATII : 82.84% ; Spleen-Macrophages : 80.08% ; Lung-Ciliated cells : 79.09% ; Lung-ATI : 78.62% ; Spleen-Natural killer cells : 58.02% ; Lung-Epithelial cells : 54.74% ; Lung-Ciliated cells : 50.45% ; Lung-Endothelial cells : 45.63% ; Lung-ATI : 58.93% ; Liver-Hepatocytes : 50.34% ; Lung-ATII : 45.79% ; Liver-Liver sinusoidal endothelial cells : 41.21% ; Lung-Ciliated cells : 40.91% ; |
|
Vesicular stomatitis virus |
Lung-ATI : 88.95% ; Frontal-Excitatory neurons : 84.30% ; Lung-ATII : 82.84% ; Spleen-Macrophages : 80.08% ; Lung-Ciliated cells : 79.09% ; |
|
Human gammaherpesvirus 4 | ||
Guanarito mammarenavirus |
Frontal-Endothelial cells : 85.00% ; Lung-ATII : 46.77% ; Lung-Epithelial cells : 36.50% ; |
|
Machupo mammarenavirus |
Frontal-Endothelial cells : 85.00% ; Lung-ATII : 46.77% ; Lung-Epithelial cells : 36.50% ; |
|
Hepacivirus C |
Frontal-Endothelial cells : 85.00% ; Lung-ATII : 46.77% ; Lung-Epithelial cells : 36.50% ; Frontal-Endothelial cells : 76.67% ; Lung-ATI : 68.50% ; Lung-ATII : 54.37% ; Lung-Ciliated cells : 54.09% ; Lung-Endothelial cells : 47.94% ; Lung-ATI : 58.93% ; Liver-Hepatocytes : 50.34% ; Lung-ATII : 45.79% ; Liver-Liver sinusoidal endothelial cells : 41.21% ; Lung-Ciliated cells : 40.91% ; |
|
Mouse mammary tumor virus |
Frontal-Endothelial cells : 85.00% ; Lung-ATII : 46.77% ; Lung-Epithelial cells : 36.50% ; |
|
Canine parvovirus |
Frontal-Endothelial cells : 85.00% ; Lung-ATII : 46.77% ; Lung-Epithelial cells : 36.50% ; |
|
Feline panleukopenia virus |
Frontal-Endothelial cells : 85.00% ; Lung-ATII : 46.77% ; Lung-Epithelial cells : 36.50% ; |
|
Argentinian mammarenavirus |
Frontal-Endothelial cells : 85.00% ; Lung-ATII : 46.77% ; Lung-Epithelial cells : 36.50% ; |
|
Human mastadenovirus A |
Lung-ATI : 78.41% ; Frontal-Excitatory neurons : 63.97% ; Lung-Ciliated cells : 55.91% ; Lung-ATII : 43.74% ; Liver-Cholangiocytes : 43.73% ; |
|
Coxsackievirus B5 |
Lung-ATI : 78.41% ; Frontal-Excitatory neurons : 63.97% ; Lung-Ciliated cells : 55.91% ; Lung-ATII : 43.74% ; Liver-Cholangiocytes : 43.73% ; |
|
Coxsackievirus B4 |
Lung-ATI : 78.41% ; Frontal-Excitatory neurons : 63.97% ; Lung-Ciliated cells : 55.91% ; Lung-ATII : 43.74% ; Liver-Cholangiocytes : 43.73% ; |
|
Coxsackievirus B3 |
Lung-ATI : 78.41% ; Frontal-Excitatory neurons : 63.97% ; Lung-Ciliated cells : 55.91% ; Lung-ATII : 43.74% ; Liver-Cholangiocytes : 43.73% ; |
|
Coxsackievirus B2 |
Lung-ATI : 78.41% ; Frontal-Excitatory neurons : 63.97% ; Lung-Ciliated cells : 55.91% ; Lung-ATII : 43.74% ; Liver-Cholangiocytes : 43.73% ; |
|
Coxsackievirus B6 |
Lung-ATI : 78.41% ; Frontal-Excitatory neurons : 63.97% ; Lung-Ciliated cells : 55.91% ; Lung-ATII : 43.74% ; Liver-Cholangiocytes : 43.73% ; |
|
Human mastadenovirus D |
Lung-ATI : 78.41% ; Frontal-Excitatory neurons : 63.97% ; Lung-Ciliated cells : 55.91% ; Lung-ATII : 43.74% ; Liver-Cholangiocytes : 43.73% ; |
|
Human mastadenovirus F |
Lung-ATI : 78.41% ; Frontal-Excitatory neurons : 63.97% ; Lung-Ciliated cells : 55.91% ; Lung-ATII : 43.74% ; Liver-Cholangiocytes : 43.73% ; |
|
Human mastadenovirus E |
Lung-ATI : 78.41% ; Frontal-Excitatory neurons : 63.97% ; Lung-Ciliated cells : 55.91% ; Lung-ATII : 43.74% ; Liver-Cholangiocytes : 43.73% ; |
|
Human mastadenovirus C | ||
Simian rotavirus A strain RRV |
Lung-ATI : 73.85% ; Lung-Epithelial cells : 66.42% ; Spleen-B cells : 62.66% ; Spleen-Fibroblasts : 59.49% ; Lung-ATII : 55.82% ; Lung-Endothelial cells : 66.72% ; Lung-Ciliated cells : 64.09% ; Lung-Epithelial cells : 62.04% ; Lung-ATII : 61.40% ; Lung-ATI : 58.02% ; Lung-ATI : 64.28% ; Lung-Epithelial cells : 48.18% ; Spleen-Macrophages : 42.48% ; Lung-Ciliated cells : 40.45% ; Spleen-B cells : 40.28% ; |
|
Human rotavirus strain WA |
Lung-ATI : 73.85% ; Lung-Epithelial cells : 66.42% ; Spleen-B cells : 62.66% ; Spleen-Fibroblasts : 59.49% ; Lung-ATII : 55.82% ; |
|
Human metapneumovirus |
Lung-ATI : 73.85% ; Lung-Epithelial cells : 66.42% ; Spleen-B cells : 62.66% ; Spleen-Fibroblasts : 59.49% ; Lung-ATII : 55.82% ; |
|
Human parvovirus B19 |
Lung-ATI : 73.85% ; Lung-Epithelial cells : 66.42% ; Spleen-B cells : 62.66% ; Spleen-Fibroblasts : 59.49% ; Lung-ATII : 55.82% ; |
|
Human betaherpesvirus 5 |
Lung-ATI : 73.85% ; Lung-Epithelial cells : 66.42% ; Spleen-B cells : 62.66% ; Spleen-Fibroblasts : 59.49% ; Lung-ATII : 55.82% ; Lung-ATI : 64.28% ; Lung-Epithelial cells : 48.18% ; Spleen-Macrophages : 42.48% ; Lung-Ciliated cells : 40.45% ; Spleen-B cells : 40.28% ; Lung-ATI : 58.93% ; Liver-Hepatocytes : 50.34% ; Lung-ATII : 45.79% ; Liver-Liver sinusoidal endothelial cells : 41.21% ; Lung-Ciliated cells : 40.91% ; |
|
Mammalian orthoreovirus |
Lung-ATI : 73.85% ; Lung-Epithelial cells : 66.42% ; Spleen-B cells : 62.66% ; Spleen-Fibroblasts : 59.49% ; Lung-ATII : 55.82% ; |
|
Echovirus E8 |
Lung-ATI : 73.85% ; Lung-Epithelial cells : 66.42% ; Spleen-B cells : 62.66% ; Spleen-Fibroblasts : 59.49% ; Lung-ATII : 55.82% ; |
|
Echovirus E1 |
Lung-ATI : 73.85% ; Lung-Epithelial cells : 66.42% ; Spleen-B cells : 62.66% ; Spleen-Fibroblasts : 59.49% ; Lung-ATII : 55.82% ; |
|
Adeno-associated virus - 2 | ||
Human gammaherpesvirus 8 |
Lung-ATI : 64.28% ; Lung-Epithelial cells : 48.18% ; Spleen-Macrophages : 42.48% ; Lung-Ciliated cells : 40.45% ; Spleen-B cells : 40.28% ; |
|
West Nile virus |
Lung-ATI : 64.28% ; Lung-Epithelial cells : 48.18% ; Spleen-Macrophages : 42.48% ; Lung-Ciliated cells : 40.45% ; Spleen-B cells : 40.28% ; |
|
Human parechovirus 1 |
Lung-ATI : 64.28% ; Lung-Epithelial cells : 48.18% ; Spleen-Macrophages : 42.48% ; Lung-Ciliated cells : 40.45% ; Spleen-B cells : 40.28% ; |
|
Enterovirus A71 |
Frontal-Excitatory neurons : 63.16% ; Lung-Ciliated cells : 56.82% ; Frontal-Inhibitory neurons : 56.10% ; Frontal-Oligodendrocytes : 55.33% ; Frontal-Astrocytes : 53.23% ; |
|
Coxsackievirus A16 |
Frontal-Excitatory neurons : 63.16% ; Lung-Ciliated cells : 56.82% ; Frontal-Inhibitory neurons : 56.10% ; Frontal-Oligodendrocytes : 55.33% ; Frontal-Astrocytes : 53.23% ; |
|
Ebola virus |
Lung-ATII : 62.35% ; Lung-Macrophages : 48.52% ; Lung-Epithelial cells : 37.96% ; Lung-ATI : 31.91% ; Lung-Endothelial cells : 29.98% ; Spleen-T follicular helper cells : 60.77% ; Frontal-Astrocytes : 59.11% ; Spleen-T cells : 51.57% ; Frontal-Microglia : 48.85% ; Spleen-B cells : 47.06% ; |
|
Marburg marburgvirus |
Spleen-T follicular helper cells : 60.77% ; Frontal-Astrocytes : 59.11% ; Spleen-T cells : 51.57% ; Frontal-Microglia : 48.85% ; Spleen-B cells : 47.06% ; |
|
Xenotropic murine leukemia virus |
Lung-ATII : 56.35% ; Lung-ATI : 42.97% ; Lung-Epithelial cells : 37.23% ; Frontal-Excitatory neurons : 31.27% ; Lung-Ciliated cells : 30.91% ; |
|
Polytropic murine leukemia virus |
Lung-ATII : 56.35% ; Lung-ATI : 42.97% ; Lung-Epithelial cells : 37.23% ; Frontal-Excitatory neurons : 31.27% ; Lung-Ciliated cells : 30.91% ; |
|
Nipah henipavirus |
Lung-Endothelial cells : 55.02% ; Spleen-Endothelial cells : 50.85% ; Kidney-Endothelial cells : 36.09% ; Lung-ATI : 31.07% ; |
|
Hendra henipavirus |
Lung-Endothelial cells : 55.02% ; Spleen-Endothelial cells : 50.85% ; Kidney-Endothelial cells : 36.09% ; Lung-ATI : 31.07% ; |
|
Human papillomavirus type 16 |
Lung-ATII : 53.86% ; Frontal-Endothelial cells : 51.67% ; Lung-Endothelial cells : 38.39% ; Lung-Epithelial cells : 34.31% ; Liver-Hepatocytes : 33.72% ; |
|
Rhinovirus C |
Lung-Ciliated cells : 53.64% ; |
|
JC polyomavirus |
Frontal-Excitatory neurons : 51.38% ; |
|
Varicella Zoster Virus |
Frontal-Excitatory neurons : 49.60% ; Lung-ATI : 43.86% ; Frontal-Endothelial cells : 33.33% ; Spleen-Macrophages : 32.52% ; Spleen-B cells : 31.33% ; |
|
Human alphaherpesvirus 3 |
Frontal-Excitatory neurons : 49.60% ; Lung-ATI : 43.86% ; Frontal-Endothelial cells : 33.33% ; Spleen-Macrophages : 32.52% ; Spleen-B cells : 31.33% ; |
|
Jaagsiekte sheep retrovirus |
Frontal-Endothelial cells : 45.00% ; Lung-Ciliated cells : 35.91% ; |
|
Lymphocytic choriomeningitis mammarenavirus |
Kidney-Podocytes : 42.19% ; Lung-ATI : 38.69% ; |
|
Latino mammarenavirus |
Kidney-Podocytes : 42.19% ; Lung-ATI : 38.69% ; |
|
Oliveros mammarenavirus |
Kidney-Podocytes : 42.19% ; Lung-ATI : 38.69% ; |
|
Lassa mammarenavirus |
Kidney-Podocytes : 42.19% ; Lung-ATI : 38.69% ; |
|
Coxsackievirus A10 |
Lung-Ciliated cells : 41.36% ; |
|
Feline leukemia virus strain C/FA27 |
Lung-ATII : 38.41% ; |
|
Human mastadenovirus B |
Spleen-B cells : 37.98% ; Spleen-Dendritic cells : 35.91% ; |
|
Amphotropic murine leukemia virus |
Frontal-Smooth muscle cells : 32.95% ; |
|
Feline leukemia virus strain B/lambda-B1 |
Frontal-Smooth muscle cells : 32.95% ; |
|
Gibbon ape leukemia virus |
Frontal-Smooth muscle cells : 32.95% ; |
|
Rinderpest morbillivirus |
Spleen-Naive T cells : 32.81% ; |
|
Phocine morbillivirus |
Spleen-Naive T cells : 32.81% ; |
|
Measles morbillivirus |
Spleen-Naive T cells : 32.81% ; |
|
Canine morbillivirus |
Spleen-Naive T cells : 32.81% ; |